<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510144</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00064296</org_study_id>
    <nct_id>NCT02510144</nct_id>
  </id_info>
  <brief_title>Skin Prep to Reduce Postoperative Shoulder Infection</brief_title>
  <official_title>Adjusting Skin Prep to Decrease Risk of P. Acnes Related Shoulder Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland, Baltimore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Maryland, Baltimore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propionibacterium acnes is the most common pathogen identified from a surgical site infection
      in the shoulder. Standard skin preps do not prevent this type of infection. Patients will
      undergo either a chlorhexidine or benzoyl peroxide prep in days leading up to surgery.
      Bacterial burden will be determined at the time of surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After surgical posting, patients will be randomized to chlorhexidine or benzoyl peroxide
      group. The solutions used will be 5% benzoyl peroxide emollient foam and 4% chlorhexidine
      gluconate skin cleanser. Participants will be instructed to conduct skin wash using the
      appropriate solution in the shower over the operative shoulder and axilla for three mornings
      prior to surgery (pre op day -2, pre op day -1, and morning of surgery). Specific
      instructions will include leaving the solution on the skin for three minutes and avoiding
      contact with eyes, ears, and mouth. Proper technique will be demonstrated at time of patient
      recruitment and given as a handout with the wash solution provided. A reminder phone call
      will occur two days before surgery to remind patients of proper procedure to improve
      compliance. On the day of surgery, patients be interviewed about pre-operative compliance.

      On the day of surgery, two cultures will be taken in three separate sites on both shoulders
      (anterior, lateral, and posterior) using a detergent scrub technique, the current
      dermatologic standard for biopsy of the deep sebaceous glands. (3,11) This procedure is
      typically performed on the skin of awake patients and causes minimal pain and skin
      irritation. Cultures will be evaluated in our lab. We will also test for hemolysis as a
      possible indicator of a more virulent strain in the literature.

      The research team may take photos of the shoulder skin being swabbed. Photos will not include
      the facial or defining characteristics. Photos may be taken either in the clinic at time of
      recruitment or in the operating room when samples are being taken.

      Inclusion criteria: all patients undergoing open shoulder surgery or shoulder arthroscopy.
      Exclusion criteria: anyone with a history of allergic reaction to chlorhexidine or benzoyl
      peroxide. Anyone with a history of previous shoulder infection, current open skin lesions
      around the shoulder or the use of current anti-acne medications around the shoulder.

      Healthy volunteer portion: Healthy volunteers will respond to the study from fliers on
      campus. A cotton swab test on both shoulders will be performed prior to any treatment. If a
      threshold of P. Acnes is met (&gt;1000 Colony Forming Units (CFUs)) then volunteers will be
      randomized to the same two groups and retested after three days of unilateral treatment.
      Finally, volunteers will undergo repeat cotton swab testing one week after 3 day wash was
      finalized.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">July 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Swab and Culture With Colony Forming Units (CFUs)</measure>
    <time_frame>At time of surgery</time_frame>
    <description>Preoperative Cutibacterium acnes shoulder burden. Skin cultures of both shoulders were obtained via a detergent scrub technique the day of surgery at anterior, lateral, and posterior sites and the axilla.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical Site Infection That Requires Antibiotics</measure>
    <time_frame>At one year</time_frame>
    <description>Cultures were evaluated in our lab and also tested for hemolysis as a possible indicator of a more virulent strain in the literature.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Shoulder Infection</condition>
  <arm_group>
    <arm_group_label>Chlorhexidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Benzoyl Peroxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Skin Prep Chlorhexidine</intervention_name>
    <description>3 day preoperative skin prep prior to surgery</description>
    <arm_group_label>Chlorhexidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Skin Prep Benzoyl Peroxide</intervention_name>
    <description>3 day preoperative skin prep prior to surgery</description>
    <arm_group_label>Benzoyl Peroxide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18

          -  Indicated for shoulder surgery

        Exclusion Criteria:

          -  History of previous shoulder infection

          -  Allergy to Chlorhexidine or benzoyl peroxide

          -  Current use of anti-acne medicine around the shoulder

          -  Patient is pregnant or concerned about pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Maryland Midtown Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2015</study_first_posted>
  <results_first_submitted>November 4, 2019</results_first_submitted>
  <results_first_submitted_qc>January 17, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 29, 2020</results_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland, Baltimore</investigator_affiliation>
    <investigator_full_name>Mohit N. Gilotra</investigator_full_name>
    <investigator_title>Assistant Professor of Orthopaedics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Benzoyl Peroxide</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 20, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT02510144/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Chlorhexidine</title>
          <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)
Skin Prep Chlorhexidine: 3 day preoperative skin prep prior to surgery</description>
        </group>
        <group group_id="P2">
          <title>Benzoyl Peroxide</title>
          <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)
Skin Prep Benzoyl Peroxide: 3 day preoperative skin prep prior to surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Chlorhexidine</title>
          <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)
Skin Prep Chlorhexidine: 3 day preoperative skin prep prior to surgery</description>
        </group>
        <group group_id="B2">
          <title>Benzoyl Peroxide</title>
          <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)
Skin Prep Benzoyl Peroxide: 3 day preoperative skin prep prior to surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" lower_limit="18" upper_limit="88"/>
                    <measurement group_id="B2" value="51" lower_limit="23" upper_limit="77"/>
                    <measurement group_id="B3" value="51" lower_limit="18" upper_limit="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.2" lower_limit="20.0" upper_limit="47.4"/>
                    <measurement group_id="B2" value="30.7" lower_limit="18.0" upper_limit="45.8"/>
                    <measurement group_id="B3" value="30.5" lower_limit="18.0" upper_limit="47.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Active smokers</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arthroplasty cases</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="39"/>
                    <count group_id="B2" value="41"/>
                    <count group_id="B3" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Skin Swab and Culture With Colony Forming Units (CFUs)</title>
        <description>Preoperative Cutibacterium acnes shoulder burden. Skin cultures of both shoulders were obtained via a detergent scrub technique the day of surgery at anterior, lateral, and posterior sites and the axilla.</description>
        <time_frame>At time of surgery</time_frame>
        <population>8 samples/skin cultures were obtained from each participant; 4 from each shoulder. The contralateral shoulder was the control.</population>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine</title>
            <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)
Skin Prep Chlorhexidine: 3 day preoperative skin prep prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide</title>
            <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)
Skin Prep Benzoyl Peroxide: 3 day preoperative skin prep prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Swab and Culture With Colony Forming Units (CFUs)</title>
          <description>Preoperative Cutibacterium acnes shoulder burden. Skin cultures of both shoulders were obtained via a detergent scrub technique the day of surgery at anterior, lateral, and posterior sites and the axilla.</description>
          <population>8 samples/skin cultures were obtained from each participant; 4 from each shoulder. The contralateral shoulder was the control.</population>
          <units>negative skin cultures</units>
          <param>Number</param>
          <units_analyzed>skin cultures</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>skin cultures</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="164"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Negative cultures were compared on the treated side vs the non-treated side</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Negative cultures were compared on the treated side versus the non-treated side</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgical Site Infection That Requires Antibiotics</title>
        <description>Cultures were evaluated in our lab and also tested for hemolysis as a possible indicator of a more virulent strain in the literature.</description>
        <time_frame>At one year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Chlorhexidine</title>
            <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)
Skin Prep Chlorhexidine: 3 day preoperative skin prep prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Benzoyl Peroxide</title>
            <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)
Skin Prep Benzoyl Peroxide: 3 day preoperative skin prep prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Site Infection That Requires Antibiotics</title>
          <description>Cultures were evaluated in our lab and also tested for hemolysis as a possible indicator of a more virulent strain in the literature.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Chlorhexidine</title>
          <description>A preoperative Chlorhexidine gluconate solution 4.0% (i.e Hibiclens)
Skin Prep Chlorhexidine: 3 day preoperative skin prep prior to surgery</description>
        </group>
        <group group_id="E2">
          <title>Benzoyl Peroxide</title>
          <description>A preoperative 5% benzoyl peroxide wash prep (i.e. Brevoxyl-4 and Brevoxyl-8)
Skin Prep Benzoyl Peroxide: 3 day preoperative skin prep prior to surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Mohit Gilotra</name_or_title>
      <organization>University of Maryland Baltimore</organization>
      <phone>(301) 502-4102</phone>
      <email>mgilotra@som.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

